TY  - JOUR
AU  - Teixido-Tura, Gisela
AU  - Forteza, Alberto
AU  - Rodríguez-Palomares, Jose
AU  - Gonzalez-Mirelis, Jesus
AU  - Gutiérrez, Laura
AU  - Sánchez, Violeta
AU  - Ibáñez, Borja
AU  - Garcia-Dorado, David
AU  - Evangelista, Artur
PY  - 2018
DO  - 10.1016/j.jacc.2018.07.052
SN  - 0735-1097
UR  - http://hdl.handle.net/20.500.12105/9496
AB  - BACKGROUND: Beta-blockers are the standard treatment in Marfan syndrome (MFS). Recent clinical trials with limited follow-up yielded conflicting results on losartan's effectiveness in MFS. OBJECTIVES: The present study aimed to evaluate the benefit of...
LA  - eng
PB  - Elsevier
KW  - Marfan syndrome
KW  - aortic aneurysm
KW  - losartan
KW  - Adrenergic beta-1 Receptor Antagonists
KW  - Adult
KW  - Aneurysm, Dissecting
KW  - Angiotensin II Type 1 Receptor Blockers
KW  - Aorta
KW  - Aortic Aneurysm
KW  - Atenolol
KW  - Dilatation, Pathologic
KW  - Disease Progression
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Losartan
KW  - Magnetic Resonance Imaging, Cine
KW  - Male
KW  - Marfan Syndrome
KW  - Young Adult
TI  - Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome
TY  - journal article
ER  -